CRLF2 and central nervous system leukemia: There were no significant differences in the incidence rates of concomitant testicular infiltration, central nervous system leukemia, intracranial hemorrhage, hepatosplenomegaly, and bone pain at the diagnosis of the disease in patients with different CRLF2 expression levels (Supplementary Table 1).